Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Krogvold

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Endocrinology|January 2, 2023
Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanismKnud Josefsen, Lars Krogvold, Ivan C Gerling, et al.
The American Journal of Pathology|May 28, 2018
No Evidence for Presence of Mucosal-Associated Invariant T Cells in the Insulitic Lesions in Patients Recently Diagnosed with Type 1 DiabetesEnida Kuric, Lars Krogvold, Kristian F Hanssen, et al.
Skin Health and Disease|August 4, 2023
A toddler with systemic contact dermatitis caused by diabetes devicesAnne Viktoria Lyngstadaas, Jan-Øivind Holm, Lars Krogvold, et al.
Scientific Reports|October 28, 2022
PDE12 in type 1 diabetesHasim Tekin, Knud Josefsen, Lars Krogvold, et al.
Histochemistry and Cell Biology|February 4, 2017
An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetesCharlton Martin, Lars Krogvold, Shebani Farik, et al.
Diabetologia|March 29, 2018
Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of diseaseShiva Reddy, Lars Krogvold, Charlton Martin, et al.
BMJ Open Diabetes Research & Care|September 5, 2025
TLR5 influences the development of type 1 diabetesKarsten Buschard, Lars Krogvold, Flemming Pociot, et al.
Diabetes/Metabolism Research and Reviews|July 3, 2023
Type 1 diabetes could begin with alterations in innate anti-viral immunity, which are already at this stage associated with HLA risk haplotypesKarsten Buschard, Mathias Høj Jensen, Lars Krogvold, et al.
Cell and Tissue Research|January 11, 2021
Expression of immunoreactive inducible nitric oxide synthase in pancreatic islet cells from newly diagnosed and long-term type 1 diabetic donors is heterogeneous and not disease-associatedShiva Reddy, Lars Krogvold, Charlton Martin, et al.
The American Journal of Pathology|December 20, 2014
Expression of human leukocyte antigen class I in endocrine and exocrine pancreatic tissue at onset of type 1 diabetesOskar Skog, Stella Korsgren, Anna Wiberg, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Endocrinology|January 2, 2023
Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanismKnud Josefsen, Lars Krogvold, Ivan C Gerling, et al.
The American Journal of Pathology|May 28, 2018
No Evidence for Presence of Mucosal-Associated Invariant T Cells in the Insulitic Lesions in Patients Recently Diagnosed with Type 1 DiabetesEnida Kuric, Lars Krogvold, Kristian F Hanssen, et al.
Skin Health and Disease|August 4, 2023
A toddler with systemic contact dermatitis caused by diabetes devicesAnne Viktoria Lyngstadaas, Jan-Øivind Holm, Lars Krogvold, et al.
Scientific Reports|October 28, 2022
PDE12 in type 1 diabetesHasim Tekin, Knud Josefsen, Lars Krogvold, et al.
Histochemistry and Cell Biology|February 4, 2017
An immunohistochemical study of nitrotyrosine expression in pancreatic islets of cases with increasing duration of type 1 diabetes and without diabetesCharlton Martin, Lars Krogvold, Shebani Farik, et al.
Diabetologia|March 29, 2018
Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of diseaseShiva Reddy, Lars Krogvold, Charlton Martin, et al.
BMJ Open Diabetes Research & Care|September 5, 2025
TLR5 influences the development of type 1 diabetesKarsten Buschard, Lars Krogvold, Flemming Pociot, et al.
Diabetes/Metabolism Research and Reviews|July 3, 2023
Type 1 diabetes could begin with alterations in innate anti-viral immunity, which are already at this stage associated with HLA risk haplotypesKarsten Buschard, Mathias Høj Jensen, Lars Krogvold, et al.
Cell and Tissue Research|January 11, 2021
Expression of immunoreactive inducible nitric oxide synthase in pancreatic islet cells from newly diagnosed and long-term type 1 diabetic donors is heterogeneous and not disease-associatedShiva Reddy, Lars Krogvold, Charlton Martin, et al.
The American Journal of Pathology|December 20, 2014
Expression of human leukocyte antigen class I in endocrine and exocrine pancreatic tissue at onset of type 1 diabetesOskar Skog, Stella Korsgren, Anna Wiberg, et al.
Pageof 6